Katherine Goodrich - Nov 13, 2024 Form 3 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Scott Sieckert, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Nov 13, 2024
Transactions value $
$0
Form type
3
Date filed
11/15/2024, 04:36 PM

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney